Prof. Dr. Loo has conducted fascinating research over the 12 years in The University of Malaya, particularly in Lifelong Machine Learning, Explainable Robotics, Explainable AI and recently in Trustworth & Sustainable AI. His numerous publications on the topic have been well-received and have made a substantial contribution to the Continual Machine Intelligence.  He has published more than 200 peer-reviewed journal and conference papers on neurorobotics and machine intelligence. In high-impact journals such as IEEE Transactions on Neural Networks and Learning Systems, Neural Networks, Journal of Neural Systems, IEEE Transactions on Cognitive and Developmental Systems, IEEE Transactions on Cybernetics, to name a few. Prof. Loo is also the recipient of JSPS fellowship award from Japan and the Georg Forster Fellowship award from the Humboldt Foundation, Germany, Belt and Road Academic Fellowship Scheme, China, and the Fulbright Fellowship from US. He has been the visiting professor of Osaka Metropolitan University, Japan, and King Mongkut's Institute of Technology Ladkrabang, Thailand and Adjunct Professor in The Harry Butler Institute, Murdoc University. He has applied the developed theory to medical diagnosis, prognosis, and brain-inspired Machine Intelligence, and the potential of his research findings has been successfully demonstrated in various domains, including digital healthcare and cognitive robotics. Chu Kiong has been recognized for his excellence in applied research that has commercial potential based on the 10 patents filed. He is one of the founders of UM spin-off company, UMCH Sdn. Bhd. specializing in AI-enabled connected healthcare solutions.   Moreover, he is honoured Malaysia’s Research Star Award 2019 - Research and Innovation Excellence Awards, from the Ministry of Education as one of the most influential researchers in Malaysia. He received the Top Research Scientist Malaysia (TRSM) award 2020 from the Academy of Science Malaysia. 

Prof. Ali Mohammad Sharifi is a scholar with over 27 years of experience in Molecular Pharmacology at the Iran University of Medical Sciences and currently joined as a professor of regenerative Medicine in the Tissue Engineering Group at NOCERAL, department of Orthopedics Surgery, School of Medicine. He obtained his Ph.D. from the University of Glasgow in 1992 and in 2018, he further enriched his expertise by acquiring a Tissue Banking Diploma from the National University of Singapore. Throughout his career, Prof. Sharifi has undertaken international research, including working at McGill University in Canada and at Max Plank Institute in Germany. His research output includes over 100 publications in high-impact journals, along with several patented innovations. He has held various administrative and editorial roles in academia, and has served as a peer reviewer for numerous high-impact journals. His dedication to education is evident through his mentorship of undergraduate and postgraduate students, particularly Ph.D. candidates specializing in molecular medicine, tissue engineering, molecular pharmacology, and cell therapy.  Prof. Sharifi's research expertise involves the fields of cell therapy and regenerative Pharmacology, with a particular emphasis on translational medicine. His extensive body of work includes pioneering studies on pharmacological priming, therapeutic angiogenesis, and innovative strategies to enhance the effectiveness of stem cell therapy by manipulating HIF-1α stabilization, especially in the context of diabetes. Additionally, his research activities include bone and cartilage regeneration, employing a diverse array of strategies such as stem cells and biologically derived products like amniotic membrane extract and mesenchymal stem cell-derived secretome. He has also explored the potential of herbal agents in regenerative medicine.  His contributions extend to the development of custom-made bio-implants for addressing large bone defects and the design and production of various wound dressings, with a specific focus on diabetic wound healing. In recent times, Prof. Sharifi has harnessed the transformative power of CRISPR gene editing technology to combat synovial fibrosis induced by osteoarthritis. In summary, Professor Sharifi is an active scientist in the field of Molecular Pharmacology and Regenerative Medicine, exemplifying innovation, and dedication to advancing scientific knowledge for improvement of healthcare and human well-being.  

Azmin Azliza Aziz is a Senior Lecturer in the Decision Science department at the Faculty of Business and Economics, Universiti Malaya. She holds a BSc. in Industrial Mathematics from Universiti Teknologi Malaysia (UTM), a Masters in Applied Statistics from Macquarie University, Sydney, and a PhD in Operations Research from the University of Warwick. She is currently the Coordinator for the Bachelor of Business Administration (BBA) program at the faculty. Dr. Azliza’s research interests extend to optimization, digital technologies, IoT, supply chain, halal logistics, and social media studies, areas where she supervises numerous PhD and Masters students. Over the past decade, she has contributed articles to esteemed journals, authored multiple book chapters, and presented at various conferences. Leading recent research grants on mobile health applications and the Internet of drones, Dr. Azliza’s work was honored with two medals at the Malaysia Technology Expo 2021. ‪